Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 3
1994 1
1998 2
2000 2
2001 4
2002 3
2003 2
2004 5
2005 1
2006 1
2007 1
2008 1
2009 1
2010 1
2011 2
2012 4
2013 7
2014 3
2015 8
2016 8
2017 5
2018 4
2019 7
2020 6
2022 1
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Peptide-guided nanoparticles for glioblastoma targeting.
Säälik P, Lingasamy P, Toome K, Mastandrea I, Rousso-Noori L, Tobi A, Simón-Gracia L, Hunt H, Paiste P, Kotamraju VR, Bergers G, Asser T, Rätsep T, Ruoslahti E, Bjerkvig R, Friedmann-Morvinski D, Teesalu T. Säälik P, et al. Among authors: asser t. J Control Release. 2019 Aug 28;308:109-118. doi: 10.1016/j.jconrel.2019.06.018. Epub 2019 Jun 27. J Control Release. 2019. PMID: 31255690
Response to the future of the EANS neurosurgeons of Europe, unite!
Beneš V, Grotenhuis A, Schramm J, Buki A, Akalan N, Asser T, Brennum J, Constantini S, D'Avella D, Hutchinson P, van Loon J. Beneš V, et al. Among authors: asser t. Acta Neurochir (Wien). 2015 Nov;157(11):1829-30. doi: 10.1007/s00701-015-2566-6. Epub 2015 Sep 3. Acta Neurochir (Wien). 2015. PMID: 26329735 No abstract available.
Tumor-penetrating peptide for systemic targeting of Tenascin-C.
Lingasamy P, Tobi A, Kurm K, Kopanchuk S, Sudakov A, Salumäe M, Rätsep T, Asser T, Bjerkvig R, Teesalu T. Lingasamy P, et al. Among authors: asser t. Sci Rep. 2020 Apr 2;10(1):5809. doi: 10.1038/s41598-020-62760-y. Sci Rep. 2020. PMID: 32242067 Free PMC article.
[Health telematics/telemedicine in the republic of Estonia].
Köhler F, Fotuhi P, Schierbaum C, Dietel M, Baumann G, Lange M, Asser T. Köhler F, et al. Among authors: asser t. Dtsch Med Wochenschr. 2004 Apr 30;129 Suppl 1:S17-20. doi: 10.1055/s-2004-824838. Dtsch Med Wochenschr. 2004. PMID: 15133737 Review. German.
Incidence and Mortality of Parkinson's Disease in Estonia.
Kadastik-Eerme L, Taba N, Asser T, Taba P. Kadastik-Eerme L, et al. Among authors: asser t. Neuroepidemiology. 2019;53(1-2):63-72. doi: 10.1159/000499756. Epub 2019 Apr 16. Neuroepidemiology. 2019. PMID: 30991384
Prevalence of Parkinson's disease in Estonia.
Taba P, Asser T. Taba P, et al. Among authors: asser t. Acta Neurol Scand. 2002 Nov;106(5):276-81. doi: 10.1034/j.1600-0404.2002.01286.x. Acta Neurol Scand. 2002. PMID: 12371921
The increasing prevalence of Parkinson's disease in Estonia.
Kadastik-Eerme L, Taba N, Asser T, Taba P. Kadastik-Eerme L, et al. Among authors: asser t. Acta Neurol Scand. 2018 Sep;138(3):251-258. doi: 10.1111/ane.12948. Epub 2018 Apr 29. Acta Neurol Scand. 2018. PMID: 29707760
73 results